ABCG2 and colorectal carcinoma: In addition, analysis of ABCC4 and ABCG2 mRNA expression levels revealed no statistically significant differences between FOLFIRI (Figure 9C)- and FOLFOX (Figure 9D)-resistant and -sensitive CRC patients.